Graz, Austria

Doris Fuertinger

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2019-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Doris Fuertinger

Introduction

Doris Fuertinger is a notable inventor based in Graz, Austria. She has made significant contributions to the field of medical technology, particularly in the area of clinical trials and patient management. With a total of two patents to her name, her work has the potential to impact healthcare practices significantly.

Latest Patents

Doris Fuertinger's latest patents include a "System and method of conducting in silico clinical trials." This invention describes computer systems and methods for generating virtual patients, which can be utilized to conduct virtual clinical trials. These virtual patients mathematically represent a physiological system in an actual patient for a health condition, allowing for the assessment of therapy efficacy and potential adverse effects.

Another significant patent is the "System and method of modeling erythropoiesis and its management." This method focuses on adjusting a patient's hematocrit and hemoglobin concentration using an erythropoiesis stimulating agent (ESA) regimen. It involves obtaining patient parameters to predict the patient's blood values and adjusting the ESA administration regimen accordingly to achieve desired health outcomes.

Career Highlights

Doris Fuertinger is currently employed at Fresenius Medical Care Holdings, Inc., where she continues to innovate in the medical field. Her work is characterized by a strong focus on improving patient care through advanced technological solutions.

Collaborations

Some of her notable coworkers include Franz Kappel and Peter Kotanko, who contribute to her research and development efforts in the medical technology sector.

Conclusion

Doris Fuertinger's contributions to medical technology through her patents demonstrate her commitment to enhancing patient care and clinical practices. Her innovative approaches have the potential to transform how clinical trials and patient management are conducted.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…